# Atlantic Lipid Lowering Treatment Optimization Program

> **NCT06439654** · NA · RECRUITING · sponsor: **Atlantic Health System** · enrollment: 250 (estimated)

## Conditions studied

- Familial Hypercholesterolemia
- Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia
- Apolipoprotein B 100, Familial Defective
- High Density Lipoprotein Deficiency
- Low-Density-Lipoid-Type Hyperlipoproteinemia

## Interventions

- **OTHER:** Supportive care

## Key facts

- **NCT ID:** NCT06439654
- **Lead sponsor:** Atlantic Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439654, "Atlantic Lipid Lowering Treatment Optimization Program". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06439654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*